These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 25265977)

  • 1. Healthy obese versus unhealthy lean: the obesity paradox.
    Lavie CJ; De Schutter A; Milani RV
    Nat Rev Endocrinol; 2015 Jan; 11(1):55-62. PubMed ID: 25265977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
    Pagidipati NJ; Zheng Y; Green JB; McGuire DK; Mentz RJ; Shah S; Aschner P; Delibasi T; Rodbard HW; Westerhout CM; Holman RR; Peterson ED;
    Am Heart J; 2020 Jan; 219():47-57. PubMed ID: 31707324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.
    Elagizi A; Kachur S; Lavie CJ; Carbone S; Pandey A; Ortega FB; Milani RV
    Prog Cardiovasc Dis; 2018; 61(2):142-150. PubMed ID: 29981771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates on obesity and the obesity paradox in cardiovascular diseases.
    Tutor AW; Lavie CJ; Kachur S; Milani RV; Ventura HO
    Prog Cardiovasc Dis; 2023; 78():2-10. PubMed ID: 36481212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox.
    Lavie CJ; McAuley PA; Church TS; Milani RV; Blair SN
    J Am Coll Cardiol; 2014 Apr; 63(14):1345-54. PubMed ID: 24530666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity paradox in different populations: evidence and controversies.
    Goel K; Lopez-Jimenez F; De Schutter A; Coutinho T; Lavie CJ
    Future Cardiol; 2014 Jan; 10(1):81-91. PubMed ID: 24344665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secular trends in cardiovascular disease risk factors according to body mass index in US adults.
    Gregg EW; Cheng YJ; Cadwell BL; Imperatore G; Williams DE; Flegal KM; Narayan KM; Williamson DF
    JAMA; 2005 Apr; 293(15):1868-74. PubMed ID: 15840861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and Prevalence of Cardiovascular Diseases and Prognosis-The Obesity Paradox Updated.
    Lavie CJ; De Schutter A; Parto P; Jahangir E; Kokkinos P; Ortega FB; Arena R; Milani RV
    Prog Cardiovasc Dis; 2016; 58(5):537-47. PubMed ID: 26826295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity paradox in joint replacement for osteoarthritis - truth or paradox?
    Kunutsor SK; Whitehouse MR; Blom AW
    Geroscience; 2022 Apr; 44(2):651-659. PubMed ID: 34453272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and prognosis in chronic diseases--impact of cardiorespiratory fitness in the obesity paradox.
    Lavie CJ; Schutter AD; Archer E; McAuley PA; Blair SN
    Curr Sports Med Rep; 2014; 13(4):240-5. PubMed ID: 25014389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years.
    McAuley PA; Kokkinos PF; Oliveira RB; Emerson BT; Myers JN
    Mayo Clin Proc; 2010 Feb; 85(2):115-21. PubMed ID: 20118386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of polyvascular disease on the obesity paradox in vascular surgery patients.
    van Kuijk JP; Flu WJ; Galal W; Chonchol M; Goei D; Verhagen HJ; Bax JJ; Poldermans D
    J Vasc Surg; 2011 Feb; 53(2):399-406. PubMed ID: 20965685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity paradox in group 1 pulmonary hypertension: analysis of the NIH-Pulmonary Hypertension registry.
    Mazimba S; Holland E; Nagarajan V; Mihalek AD; Kennedy JLW; Bilchick KC
    Int J Obes (Lond); 2017 Aug; 41(8):1164-1168. PubMed ID: 28209971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and the "obesity paradox" in cardiovascular diseases.
    Lavie CJ; Milani RV; Ventura HO
    Clin Pharmacol Ther; 2011 Jul; 90(1):23-5. PubMed ID: 21691270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
    Lavie CJ; Milani RV; Ventura HO
    J Am Coll Cardiol; 2009 May; 53(21):1925-32. PubMed ID: 19460605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis.
    Kramer CK; Zinman B; Retnakaran R
    Ann Intern Med; 2013 Dec; 159(11):758-69. PubMed ID: 24297192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-Based Estimates of Decreases in Quality-Adjusted Life Expectancy Associated with Unhealthy Body Mass Index.
    Jia H; Zack MM; Thompson WW
    Public Health Rep; 2016; 131(1):177-84. PubMed ID: 26843684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study.
    Costanzo P; Cleland JG; Pellicori P; Clark AL; Hepburn D; Kilpatrick ES; Perrone-Filardi P; Zhang J; Atkin SL
    Ann Intern Med; 2015 May; 162(9):610-8. PubMed ID: 25938991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fitness, fatness, and cardiovascular risk factors in type 2 diabetes: look ahead study.
    Wing RR; Jakicic J; Neiberg R; Lang W; Blair SN; Cooper L; Hill JO; Johnson KC; Lewis CE;
    Med Sci Sports Exerc; 2007 Dec; 39(12):2107-16. PubMed ID: 18046181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.